RALA and neoplasm: And since analogous results were obtained when mice implanted with CT26 syngeneic colon cancer tumors were similarly treated (Figures 4C, D), we conclude that Ral-TLR7-1a inhibition of tumor growth is likely a property of most Treg-containing tumors.